Core Insights - China Biopharmaceutical's innovative drug, Moxifloxacin capsules (brand name: Saitanxin), has been officially launched in Dingdang Health's pharmacies just two weeks after receiving market approval, providing a significant new treatment option for patients with relevant indications [1] Group 1 - Dingdang Health achieved a remarkable speed in bringing new products to market, completing the entire process from product introduction to official sales in just 7 days [1] - The efficiency of Dingdang Health's new product launch is attributed to its "Agile Solutions for Drug Accessibility," which integrates internal business, quality control, operations, and technology platforms to create a "green channel" for new product launches [1] - Dingdang Health's specialized pharmacies are equipped with dedicated pharmacist teams that offer medication guidance and comprehensive health management services throughout the patient's health journey, ensuring patients not only "get the medication" but also "manage their health well" [1] Group 2 - Starting from April 2025, Dingdang Health will launch the "Life Ark Plan" to address the urgent needs of patients for various new specialty drugs, focusing on major disease areas such as oncology, rare diseases, endocrinology, and autoimmune diseases [1] - The company aims to build a professional drug solution framework by deepening collaborations with pharmaceutical companies and leveraging its online digital capabilities along with professional teams of doctors and pharmacists to ensure that cutting-edge drugs and treatment plans efficiently and accurately reach patients nationwide [1]